Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.41697 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.38519 | 16 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.38342 | 16 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.31354 | 15 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.32433 | 15 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.44217 | 16 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.42979 | 16 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.37007 | 16 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.37036 | 16 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.37078 | 15 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.37188 | 16 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.35013 | 15 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.38388 | 16 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.38041 | 16 |